Therapeutic areas: Immunology, Rare Disease, Hematology
argenx reps cover efgartigimod (Vyvgart) across three approved indications — generalized myasthenia gravis (gMG), CIDP, and ITP — with a fourth (bullous pemphigoid) in review. Rare neurology and immunology call lists are small but each call carries significant clinical and commercial weight. Reps describe one of the most scientifically demanding environments in pharma.
Key products: Vyvgart, Vyvgart Hytrulo
argenx reps cover efgartigimod (Vyvgart) across three approved indications — generalized myasthenia gravis (gMG), CIDP, and ITP — with a fourth (bullous pemphigoid) in review. Rare neurology and immun